Vivalytic: Molecular Diagnostics Platform for Rapid COVID-19 Testing

Added:

Testing Bottleneck
Hospital Deployment
Rapid Results Impact
How Vivalytic Works
Versatile Use Cases
Lab-on-a-Chip Tech
Open Platform Benefits
Serendipity and Impact

Testing Bottleneck

2:02
Playing Section
  • 1

    Podcast explores how tech addresses pandemic testing delays.

  • 2

    Introduces Vivalytic for fast, automated molecular diagnostics.

  • 3

    Device size of a small PC, uses lab-on-a-chip technology.

Principles of Polymerase Chain Reaction (PCR) and nucleic acid amplification used in molecular diagnostics.
Basic virology of SARS-CoV-2, specifically its RNA genome and how it differs from antigen-based targets.
Fundamental concepts of microfluidics and 'lab-on-a-chip' technology, including fluid behavior at microscopic scales.
The distinction between traditional, centralized laboratory testing and decentralized, Point-of-Care (POC) testing.
Multiplex molecular panels, exploring how a single chip can simultaneously test for multiple respiratory pathogens (e.g., Influenza, RSV, COVID-19).
The socioeconomic and epidemiological impacts of rapid testing on pandemic surveillance and hospital triage systems.
Advanced manufacturing processes and material science challenges involved in mass-producing microfluidic cartridges.
Emerging diagnostic modalities, such as CRISPR-based point-of-care diagnostics and isothermal amplification techniques (e.g., LAMP).
2.5K views19likes28:48@boschglobalOriginal Release: 2020-12-11

Vivalytic is a universal molecular diagnostics platform that miniaturizes laboratory processes onto a chip-sized cartridge, enabling fully automated pathogen detection through nucleic acid amplification (PCR) and microarray analysis in approximately 39 minutes, with the 'Vegas rule' ensuring that all sample processing occurs within the sealed cartridge to prevent contamination between tests.